Recent Updates
Recently added Catalysts
ETON Positive Sentiment Score: 70/100

Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th

Friday, February 20, 2026 1 min read
Key Takeaway: Eton Pharmaceuticals will participate in the Leerink Partners Global Healthcare Conference on March 11, 2026, in Miami, Florida. The company's executive leadership team will host one-on-one meetings during the event. Eton is focused on developing treatments for rare diseases and has several commercial products and candidates in late-stage development.

Market Sentiment Analysis

POSITIVE FACTORS

  • Eton Pharmaceuticals is actively participating in a significant healthcare conference.
  • The company has a strong focus on rare diseases, showcasing its commitment to this niche.
  • Eton has multiple commercial products and late-stage candidates, indicating robust development.

Full Press Release Details

DEER PARK, Ill., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host one-on-one meetings at the Leerink Partners Global Healthcare Conference on Wednesday, March 11, 2026 in Miami, Florida.
To schedule a 1x1 meeting with the Company, please contact your Leerink Partners institutional sales representative.
About Eton PharmaceuticalsEton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eight commercial rare disease products: KHINDIVI™, INCRELEX®, ALKINDI SPRINKLE®, GALZIN®, PKU GOLIKE®, Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has four additional product candidates in late-stage development: Amglidia®, ET-700, ET-800 and ZENEO®hydrocortisone autoinjector. For more information, please visit our website atwww.etonpharma.com.

Investor Relations:Lisa M. Wilson, In-Site Communications, Inc.T: 212-452-2793E:lwilson@insitecony.com

Source: Eton Pharmaceuticals.

Frequently Asked Questions

When is Eton Pharmaceuticals participating in the conference?

Eton Pharmaceuticals will participate in the conference on March 11, 2026.

Where is the Leerink Partners Global Healthcare Conference held?

The conference will be held in Miami, Florida.

What is Eton Pharmaceuticals focused on?

Eton Pharmaceuticals focuses on developing treatments for rare diseases.

How can one schedule a meeting with Eton at the conference?

To schedule a meeting, contact your Leerink Partners institutional sales representative.

Tags: ETON Viatris Investor Conferences Healthcare Eton Pharmaceuticals Leerink Partners rare diseases healthcare conference
Last updated: Feb 20, 2026